US Patent Issued to SANTEN PHARMACEUTICAL, Boehringer Ingelheim International on Aug. 25 for "Agent for treating myopia, preventing myopia and/or suppressing myopia progression" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,715, issued on Aug. 25, was assigned to SANTEN PHARMACEUTICAL Co. LTD. (Osaka, Japan) and Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Agent for treating myopia, preventing myopia and/or suppressing myopia progression" was invented by Takaaki Inaba (Ikoma, Japan) and Masatomo Kato (Ikoma, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for treating myopia, preventing myopia and/or suppressing myopia progression, comprising (+)-11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one or a salt thereof as an ...